Displaying 1161 - 1180 of 1557
Health Care and the FTC: The Agency as Prosecutor and Policy Wonk
FTC Halts Physician Price-Fixing in Cincinnati Area
FTC Requests Re-Hearing in Schering-Plough Case
Announced Actions for April 22, 2005
Announced Actions for April 19, 2005
Preferred Health Services, Inc., In the Matter of
The order prohibits Preferred Health Services from orchestrating collective agreements and other terms for physician services when negotiating with health insurance plans and other third party payers. According to the complaint these agreements among the physician-hospital organization of doctors and the Oconee Memorial Hospital in northwestern South Carolina to collectively negotiate fees and terms of services could lead to higher health care costs and limited physician access.
Announced Action for April 7, 2005
Chicago-Area Physicians Group Agrees Not to Fix Prices
California Pacific Medical Group, Inc., In the Matter of
With an administrative complaint issued on July 8, 2003 the Commission charged a San Francisco, California physicians’ organization with engaging in an agreement under which its competing members agreed collectively on the price and other terms on which they would enter into contracts with health plans or other third party payers. The complaint also alleged that Brown and Toland directed its physicians to end their preexisting contracts with payers and required its physician members to charge specified prices in all Preferred Provider Organization contracts. A final consent order prohibits Brown and Toland from negotiating with payers on behalf of physicians, refusing to deal with payers, and setting terms for physicians to deal with payers, unless the physicians are clinically or financially integrated.
In Letter to Virginia State Delegate, FTC Staff Supports Continued Competition in the Provision of Optometric Care to States Consumers
Federal Trade Commission Staff Cites Opposition to North Dakota PBM Bill
South Carolina Doctors Group Barred from Fixing Prices
FTC Issues Study on Competition in Contact Lens Market
Announced Action for February 11, 2005
Teva Pharmaceuticals USA, Inc. v. Pfizer, Inc.
Announced Action for February 4, 2005
Genzyme Corporation and Ilex Oncology, Inc., In the Matter of
A consent order allowed Genzyme’s acquisition of ILEX Oncology, Inc., but requires the companies to divest certain assets in the market for solid organ transplant acute therapy drugs. Specifically, Genzyme is required to divest all contractual rights related to ILEX’s Campath®, an immunosuppressant antibody used in solid organ transplants to Schering AG.
Displaying 1161 - 1180 of 1557